Parexel International (PRXL)

Add to Watchlists
Create an Alert
49.59 -0.66  -1.31% NASDAQ Apr 22, 8:00PM BATS Real time Currency in USD
View Full Chart
PRXL Price Chart
View All Events

PRXL Events

Date Type Description
Apr 30 Misc Parexel International Corporation Q3 2014 Earning Conference Call
Apr 29 Earnings Parexel International Corporation Q3 2014 Earning Result. Estimate: 0.53.
Mar 04 Misc Parexel International at Raymond James Financial Inc Institutional Investors Conference
Jan 30 Misc Q2 2014 Parexel International Earnings Conference Call
Jan 29 Earnings Parexel International Corporation Second Quarter Earnings Results. Estimate: 0.49.
Dec 05 Misc AGM Event for Parexel International Corp
Oct 30 Misc Parexel Announces Date of First Quarter Fiscal Year 2014 Earnings Release and Conference Call
Oct 30 Earnings Q1 2013 Earnings Release. Estimate: 0.45.
Aug 08 Misc Parexel Announces Date of Fourth Quarter and Fiscal Year 2013 Earnings Release and Conference Call
Aug 07 Earnings PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2013 Earnings Release and Conference Call. Estimate: 0.43.
View All Performance Charts

PRXL Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Parexel International is up 24.19% over the last year vs S&P 500 Total Return up 23.42%, Icon up 48.71%, and Charles River up 37.52%.

Get Quote for

PDF Report for PRXL

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download PRXL Pro Report PDF

Portfolio Strategies Featuring PRXL

Did Parexel International make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

PRXL Profile

  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Massachusetts
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: June 30, 2014
  • Last Fiscal Quarter End: December 31, 2013
  • Last Fiscal Year End: June 30, 2013
  • NAICS: Research and Development in Biotechnology
  • NAICS Code: 541711
  • NAICS Industry: Scientific Research and Development Services
  • NAICS Industry Code: 5417
  • NAICS Sector: Professional, Scientific, and Technical Services
  • NAICS Sector Code: 54

PAREXEL International Corp. provides clinical research and development services. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS), and Perceptive Informatics (Perceptive). The company offers contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. It also provides development and commercialization continuum services, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. The company was founded by Josef von Rickenbach in 1983 and is headquartered in Waltham, Massachusetts.

Recent Quotes

Symbol Price Chg Chg % Market Cap
PRXL 49.59 -0.66 -1.31% 2.807B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.